title: Expression of p21 in SV40 large T antigen positive human pleural mesothelioma: relationship with survival.
abstract: BACKGROUND
  Mesothelioma is the most commonly occurring primary pleural neoplasm. Several studies have documented an increase in the incidence of this malignancy during the last decades. Although the association between asbestos exposure and development of mesothelioma is generally accepted, the exact mechanism of carcinogenesis is unknown. Recently, Simian virus 40 large T antigen (SV40 Tag) expression has been detected in pleural mesothelioma. The ability of SV40 oncoproteins to inactivate p53 and retinoblastoma tumour suppressor proteins has been proposed as an important step in the pathogenesis of human mesothelioma.
  
  
  METHODS
  To obtain a better understanding of the molecular mechanisms of the pathogenesis of mesothelioma, the expression of the cell cycle inhibitor p21(WAF1/CIP1) (p21), a downstream target of p53, was evaluated immunohistochemically in a group of 29 mesothelioma specimens already characterised for the presence of SV40 Tag sequences.
  
  
  RESULTS
  Statistical analysis did not reveal any correlation between p21 expression and histopathological type of mesothelioma using the kappa(2) test (p=0.577). A significant positive relationship was found between p21 expression level and the patients' overall survival according to the Kaplan-Meier survival curves and using a log rank test (median difference in survival 7 months, 95% CI 4.8 to 9.9; p<0.001).
  
  
  CONCLUSIONS
  Determination of p21 expression bears a prognostic significance in patients affected with mesothelioma, further underlining the role of SV40 in the pathogenesis of malignant pleural mesothelioma.
authors.affiliation: Laboratory C, Department for the Development of Therapeutical Programs, Center for Experimental Research, Regina Elena Cancer Institute, Rome, Italy. baldi@ifo.it
authors.forename: A
authors.initials: A
authors.lastname: Baldi
authors.forename: A M
authors.initials: AM
authors.lastname: Groeger
authors.forename: V
authors.initials: V
authors.lastname: Esposito
authors.forename: R
authors.initials: R
authors.lastname: Cassandro
authors.forename: G
authors.initials: G
authors.lastname: Tonini
authors.forename: T
authors.initials: T
authors.lastname: Battista
authors.forename: M P
authors.initials: MP
authors.lastname: Di Marino
authors.forename: B
authors.initials: B
authors.lastname: Vincenzi
authors.forename: M
authors.initials: M
authors.lastname: Santini
authors.forename: A
authors.initials: A
authors.lastname: Angelini
authors.forename: R
authors.initials: R
authors.lastname: Rossiello
authors.forename: F
authors.initials: F
authors.lastname: Baldi
authors.forename: M G
authors.initials: MG
authors.lastname: Paggi
mesh_terms: D000956:Antigens, Viral / Q000276:immunology; D050759:Cyclin-Dependent Kinase Inhibitor p21; D016213:Cyclins / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D008654:Mesothelioma / Q000378:metabolism* / Q000401:mortality; D010997:Pleural Neoplasms / Q000378:metabolism* / Q000401:mortality; D013539:Simian virus 40 / Q000276:immunology*; D016019:Survival Analysis; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: D000956:Antigens, Viral; C493956:CDKN1A protein, human; D050759:Cyclin-Dependent Kinase Inhibitor p21; D016213:Cyclins